| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698698 | Clinical Oncology | 2015 | 8 Pages |
Abstract
We present a hypofractionated schedule of postoperative prostate radiotherapy that is both well tolerated in terms of both toxicity and quality of life measures. Initial PSA control is encouraging. Further evaluation with a longer follow-up and a larger cohort is warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A. Gladwish, A. Loblaw, P. Cheung, G. Morton, H. Chung, A. Deabreu, G. Pang, A. Mamedov,